
News from startuprad.io
Top startuprad.io News

Innovation · GermanyMIG Capital, through its MIG Fonds, is investing 3 million Swiss Francs (CHF) in the Swiss start-up which designs precision drugs against eukaryotic pathogens. Digitalis Ventures co-leads the round with additional investment from Borealis Ventures, Kickfund and Venture Kick. Eukaryotic pathogens cause illness and death in animals, humans, and crops. MUNICH, Germany, and VILLIGEN, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- MIG Capital AG, one…See the Story
MIG Capital Leads CHF 7.75 Million Seed Financing for ASTRA Therapeutics
100% Center coverage: 1 sources